TY - JOUR
T1 - Sirt1 plays an important role in mediating greater functionality of human ES/iPS-derived vascular endothelial cells
AU - Homma, Koichiro
AU - Sone, Masakatsu
AU - Taura, Daisuke
AU - Yamahara, Kenichi
AU - Suzuki, Yutaka
AU - Takahashi, Kazutoshi
AU - Sonoyama, Takuhiro
AU - Inuzuka, Megumi
AU - Fukunaga, Yasutomo
AU - Tamura, Naohisa
AU - Itoh, Hiroshi
AU - Yamanaka, Shinya
AU - Nakao, Kazuwa
N1 - Funding Information:
The anti-human Flk1 antibody (KM1668) was a generous gift from Kyowa Hakko Co Ltd. Human ES cell line KhES-1 was obtained from the Institute for Frontier Medical Science, Kyoto University (Kyoto, Japan). This work was supported by the Project for Realization of Regenerative Medicine of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This work was also supported by Grants-in-Aid for Scientific Research from the Ministry of Health, Labor and Welfare, MEXT, the Takeda Science Foundation, the Japan Cardiovascular Research Foundation, and the Smoking Research Foundation. We thank Yoshie Fukuchi and Sonoko Takesue for technical assistance.
PY - 2010/9
Y1 - 2010/9
N2 - Objective: We previously succeeded in inducing and isolating vascular endothelial cells (ECs) from both human embryonic stem (ES) and induced pluripotent stem (iPS) cells. Here, we compared the functionality of human adult ECs (HAECs), human ES-derived ECs (ESECs) and human iPS-derived ECs (iPSECs). Methods and results: We compared the cell proliferative potential, potential for migration, and tolerance to oxidative stress. ESECs were significantly superior to HAECs in all of these cell functions. The cell functions of iPSECs were comparable to those of ESECSs and also superior to HAECs. We then analyzed the gene expressions of HAECs, ESECs and iPSECs, and observed that the expression level of Sirt1, a nicotinamide adenine dinucleotide (NAD+)-dependent histone deacetylase, is higher in ESECs and iPSECs than in HAECs. The inhibition of Sirt1 with a Sirt1-specific inhibitor and siRNA antagonized these differences between the three types of cells. Conclusions: Sirt1 plays a key role in the high cellular function of ESECs and iPSECs. Although further in vivo investigations are required, this study initially demonstrated the potential of ESECs and iPSECs as the cell source for regenerative medicine, and also showed the potential of ES cells as a useful tool for elucidating the molecular mechanism of cell aging.
AB - Objective: We previously succeeded in inducing and isolating vascular endothelial cells (ECs) from both human embryonic stem (ES) and induced pluripotent stem (iPS) cells. Here, we compared the functionality of human adult ECs (HAECs), human ES-derived ECs (ESECs) and human iPS-derived ECs (iPSECs). Methods and results: We compared the cell proliferative potential, potential for migration, and tolerance to oxidative stress. ESECs were significantly superior to HAECs in all of these cell functions. The cell functions of iPSECs were comparable to those of ESECSs and also superior to HAECs. We then analyzed the gene expressions of HAECs, ESECs and iPSECs, and observed that the expression level of Sirt1, a nicotinamide adenine dinucleotide (NAD+)-dependent histone deacetylase, is higher in ESECs and iPSECs than in HAECs. The inhibition of Sirt1 with a Sirt1-specific inhibitor and siRNA antagonized these differences between the three types of cells. Conclusions: Sirt1 plays a key role in the high cellular function of ESECs and iPSECs. Although further in vivo investigations are required, this study initially demonstrated the potential of ESECs and iPSECs as the cell source for regenerative medicine, and also showed the potential of ES cells as a useful tool for elucidating the molecular mechanism of cell aging.
KW - Endothelium
KW - Sirt1
KW - Stem cells
UR - http://www.scopus.com/inward/record.url?scp=77956230709&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77956230709&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2010.04.021
DO - 10.1016/j.atherosclerosis.2010.04.021
M3 - Article
C2 - 20488443
AN - SCOPUS:77956230709
SN - 0021-9150
VL - 212
SP - 42
EP - 47
JO - Atherosclerosis
JF - Atherosclerosis
IS - 1
ER -